Prolonged HCG action affects angiogenic substances and improves follicular maturation, oocyte quality and fertilization competence in patients with polycystic ovarian syndrome

Human Reproduction

Volumn 20, Issue 6, 2005, Pages 1562-1568

  Vrtačnik Bokal, Eda ^a   Meden Vrtovec, H ^a   Virant Klun, I ^a   Verdenik, I ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Oocyte fertilization competence; Oocyte quality; Polycystic ovarian syndrome; Renin angiotensin system; Vascular endothelial growth factor

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CHORIONIC GONADOTROPIN; ESTRADIOL; PRORENIN; RENIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CELL DEGENERATION; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE DEVELOPMENT; OOCYTE MATURATION; OVARY FOLLICLE MATURATION; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TIME;

EID: 20744453709     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh789     Document Type: Article

References (49)

1. Aboulghar MA, Mansour RT, Serour GI, Maguid Ramzy A and Amin YM (1997) Oocyte quality in patients with severe ovarian hyperstimulation syndrome. Fertil Steril 68,1017-1021.
2. Acosta TJ, Ozawa T, Kobayashi S, Hayashi K, Ohtani M, Kraetzl WD, Sato K, Schams D and Miyamoto A (2000) Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo. Biol Reprod 63,1253-1261.
3. Acosta TJ, Hayashi KG, Ohtani M and Miyamoto A (2003) Local changes in blood flow within the preovulatory follicle wall and early corpus luteum in cows. Reproduction 125,759-767.
4. Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J and Jacobs HS (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2,1375-1379.
5. Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S and Jacobs H (1998) Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 70,651-658.
6. Agrawal R, Jacobs H, Payne N and Conway G (2002) Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 78,1164-1169.
7. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G and Genazzani AR (1998) Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation in women enrolled in an in vitro fertilization program. Fertil Steril 70,560-564.
8. Balakier H, Sojecki A, Motamedi G and Librach C (2004) Time-dependent capability of human oocytes for activation and pronuclear formation during metaphase II arrest. Hum Reprod 19,982-987.
9. Bhal PS, Pugh ND, Chui DK, Gregory L, Walker SM and Shaw RW (1999) The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles. Hum Reprod 14,939-945.
10. Chian RC (2004) In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online 8,547-552.
11. Cresswell JL, Barker DJ and Osmond C (1997) Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 350,1131-1135.
12. Culler MD, Tarlatzis BC, Lightman A and Fernandez LA (1986) Angiotensin II like immunoreactivity in human ovarian follicular fluid. J Clin Endocrinol Metab 62,613-615.
13. Daud Al, Bumpus FM and Husain A (1990) Characterization of angiotensin I-converting enzyme (ACE)-containing follicles in the rat ovary during the estrous cycle and effects of ACE inhibitor on ovulation. Endocrinology 126,2927-2935.
14. Einspanier R, Muller K, Bieser B, Kosmann M and Schams D (1999) Differential expression of VEGF applied during in vitro maturation of oocytes. J Reprod Fertil Abstr Ser 23,7.
15. Ferrara N (2000) VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11,617-624.
16. Franks S (1989) Polycystic ovary syndrome: a changing perspective. Clin Endocrinol 31,87-120.
17. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R and Sealey JE (1986) Prorenin in high concentrations in human ovarian follicular fluid. Science 233,1422-1424.
18. Hagemann A (1997) Solution of methodological problems in prorenin measurement and investigations of tissue renin-angiotensin systems in the female reproductive tract. Dan Med Bull 44,486-498.
19. Homburg R (2002) What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Hum Reprod 17,2495-2499.
20. Homburg R, Berkowitz D, Levy T, Felderberg D, Ashkenazi J and Ben-Rafael Z (1993) In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 60,858-863.
21. Huang FJ, Huang HW, Lan KC, Kung FT, Lin YC, Chang HW and Chang SY (2002) The maturity of human cumulus-free oocytes is positively related to blastocyst development and viability. J Assist Reprod Genet 19,555-560.
22. Huang FJ, Lan KC, Kung FT, Tsai MY, Chang CY, Huang HW, Lin YC and Chang SY (2004) Human cumulus-free oocyte maturational profile and in vitro developmental potential after stimulation with recombinant versus urinary FSH. Hum Reprod 19,306-315.
23. Itskovitz J, Rubattu S, Rosenwaks Z, Liu HC and Sealey JE (1991) Relationship of follicular fluid prorenin to oocyte maturation, steroid levels, and outcome of in vitro fertilization. J Clin Endocrinol Metab 72,165-171.
24. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 83,3078-3082.
25. Kuo TC, Endo K, Dharmarajan AM, Miyazaki T, Atlas SJ and Wallach EE (1991) Direct effect of angiotensin II on the in-vitro perfused rabbit ovary. J Reprod Fertil 92,469-474.
26. Lin YC, Chang SY, Lan KC, Huang HW, Chang CY, Tsai MY, Kung FT and Huang FJ (2003) Human oocyte maturity in vivo determines the outcome of blastocyst development in vitro. J Assist Reprod Genet 20,506-512.
27. Loret de Mola JR, Goldfarb JM, Hecht BR, Babbo CJ and Friedlander MA (1999) Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles. Gynecol Endocrinol 13,155-160.
28. Luo H, Kimura K, Aoki M and Hirako M (2002a) Effect of vascular endothelial growth factor on maturation, fertilization and developmental competence of bovine oocytes. J Vet Med Sci 64,803-806.
29. Luo H, Kimura K, Aoki M and Hirako M (2002b) Vascular endothelial growth factor (VEGF) promotes the early development of bovine embryo in the presence of cumulus cells. J Vet Med Sci 64,967-971.
30. MacDougall MJ, Tan SL, Balen A and Jacobs HS (1993) A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 8,233-237.
31. Mansour RA, Aboulghar MA and Serour GI (1994) Study of the optimum time for human chorionic gonadotropin - ovum pickup interval in in vitro fertilization. J Assist Reprod Genet 11,478-481.
32. Mikkelsen AL and Lindenberg S (2001) Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction 122,587-592.
33. Palumbo A, Pourmotabbed G, Cacangiu ML, Andrade-Gordon P, Roa L, DeCherney A and Naftolin F (1993) Immunohistochemical localization of renin and angiotensin in the ovary: comparison between normal women and patients with histologically proven polycystic ovarian disease. Fertil Steril 60,280-284.
34. Peach MJ (1977) Renin-angiotensin system: biochemistry and mechanism of action. Physiol Rev 57,313-370.
35. Pellicer A, Palumbo A, DeCherney AH and Naftolin F (1988) Blockage of ovulation by an angiotensin antagonist. Science 240,1660-1661.
36. Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohi J and Simon C (1999) The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor. Fertil Steril 71,482-489.
37. Richard DE, Berra E and Pouyssegur J (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1 alpha in vascular smooth muscle cells. J Biol Chem 275,26765-26771.
38. Schenker JG and Weinstein D (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30,225-268.
39. Shoham Z, Jacobs HS and Insler V (1993) Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil Steril 59,1153-1161.
40. Simon C, Caballero-Campo P, Garcia-Velasco JA and Pellicer A (1998) Potential implications of chemokines in reproductive function: an attractive idea. J Reprod Immunol 38,169-193.
41. Tamarat R, Silvestre JS, Durie M and Levy BI (2002) Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 82,747-756.
42. Tokuyama O, Nakamura Y, Muso A, Fujino Y, Ishiko O and Ogita S (2002) Vascular endothelial growth factor concentrations in follicular fluid obtained from IVF-ET patients: a comparison of hMG, clomiphene citrate, and natural cycle. J Assist Reprod Genet 19,19-23.
43. Trounson A, Anderiesz C and Jones G (2001) Maturation of human oocytes in vitro and their developmental competence. Reproduction 121,51-75.
44. Van Blerkom J (2000) Intrafollicular influences on human oocyte developmental competence: perifollicular vascularity, oocyte metabolism and mitochondrial function. Hum Reprod 15(Suppl 2),173-188.
45. Van Blerkom J, Antczak M and Schrader R (1997) The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 12,1047-1055.
46. Veeck LL (1988) Oocyte assessment and biological performance. Ann N Y Acad Sci 541,256-274.
47. Vrtačnik Bokal E and Meden Vrtovec H (1998) Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome. Hum Reprod 13,815-821.
48. Vrtačnik Bokal E, Meden Vrtovec H, Osredkar J and Verdenik I (2003) Follicular fluid renin concentration in patients with polycystic ovaries treated with gonadotrophin in an in vitro fertilisation programme. Clin Chem Lab Med 41,663-667.
49. Yoshimura Y (1997) The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol 13,247-291.